Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned.  ...

Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

As the last meetings conclude and biotech leaders head out to catch their flights, the Business Journal has put together a recap of the week’s major news concerning Boston-area companies.

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Hundreds of Cambridge and Plainville biotech employees are facing layoffs by March 30, state filings show. Thermo Fisher Scientific, a Waltham-based biotech company, is cutting 300 positions across ...

Join us for networking, mentoring, cocktails and business savvy advice being shared. What… Boston biotech opts for reverse merger with San Diego company ...

pharmaceutical, and related companies in eastern Massachusetts create a resource that will be approached for research opportunities as well as career placement and graduate internship development.